Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B (HBRN)
7/17/2013

California, Hawaii, Maryland, Massachusetts, Michigan, Minnesota, Missouri, North Carolina, Texas, Virginia, Washington, Canada. clinicaltrials.gov

Related Summaries